{"data":[{"id":28,"type":"text","title":"Closed $74M Oversubscribed Series C led by MVM Partners","styled_title":"Closed $74M Oversubscribed Series C led by MVM Partners<\/em>","content":"\"I first connected with MVM Partners at LSI several years ago, and LSI USA has remained a consistent forum for sharing progress along the way. That relationship ultimately led to MVM leading our recent $74 million Series C.\r\n\r\nLSI created the environment for those conversations to start and, just as importantly, to continue over time until the right opportunity came together. The result is an exciting partnership that positions us to accelerate commercial expansion, strengthen our clinical evidence, and advance our product and indication pipeline.\"","logo":"https:\/\/media.lifesciencemarketresearch.com\/70779\/conversions\/Neurent_Medical_Logo-(1)-small.png","headset":"https:\/\/media.lifesciencemarketresearch.com\/70777\/conversions\/1700674381062-(1)-small.png","name":"Brian Shields","job_title":"CEO & Co-Founder","order":1},{"id":29,"type":"text","title":"Led Neurent Medical's $74M Oversubscribed Series C","styled_title":"Led Neurent Medical's $74M Oversubscribed Series C<\/em>","content":"\u201cI first met Brian Shields at LSI in 2020, and we\u2019ve stayed in touch ever since. LSI played a crucial role in helping us build a relationship, which ultimately led to MVM Partners leading Neurent Medical\u2019s $74 million Series C funding round. If we hadn't met at LSI\u2019s event, we likely would not have gotten to today\u2019s investment.\u201d","logo":"https:\/\/media.lifesciencemarketresearch.com\/70783\/conversions\/Logo_Blue_1@4x-100-small.png","headset":"https:\/\/media.lifesciencemarketresearch.com\/70781\/conversions\/1619463041545-small.png","name":"Kyle Dempsey","job_title":"Partner, MVM Partners","order":2},{"id":33,"type":"text","title":"Closed a $2.5M Series A led by Joe Kiani","styled_title":"Closed a $2.5M Series A led by Joe Kiani<\/em>","content":"\"LSI was instrumental in helping us close our $2.5M Series A. At LSI USA \u201825, I caught up with Joe Kiani, Founder of Masimo and Willow Laboratories, who ultimately led the round.\r\n\r\nFor any startups looking to build meaningful relationships and gain traction in medtech, this is one of the most effective platforms out there for meaningful and focused networking. I\u2019ll be back next year to announce progress and have already started recommending it to others.\u201d","logo":"https:\/\/media.lifesciencemarketresearch.com\/70790\/conversions\/cdx_medical_technologies_logo-small.png","headset":"https:\/\/media.lifesciencemarketresearch.com\/70791\/conversions\/1769121090282-small.png","name":"Dr. Gopal Chopra","job_title":"Co-CEO, CDX Medical Technologies","order":3},{"id":31,"type":"text","title":"Welcomed Joe Kiani as an Investor and Member of its Board of Directors","styled_title":"Welcomed Joe Kiani as an Investor and Member of its Board of Directors<\/em>","content":"\u201cI met Joe Kiani at LSI USA \u201925, and we connected over a shared belief that better data can help clinicians save limbs and lives. That meeting led to Joe joining MY01 as an investor and Board member, and together we\u2019re advancing the frontier of continuous perfusion sensing to transform patient care. LSI continues to be a remarkable catalyst for meaningful connections and collaboration.\u201d","logo":"https:\/\/media.lifesciencemarketresearch.com\/70786\/conversions\/New-Logo-01-\u00ae-small.png","headset":"https:\/\/media.lifesciencemarketresearch.com\/70787\/conversions\/1621361065763-(1)-small.png","name":"Charles Allan","job_title":"CEO, MY01","order":4},{"id":32,"type":"text","title":"Entered into a Definitive Agreement to Be Acquired by Boston Scientific","styled_title":"Entered into a Definitive Agreement to Be Acquired by Boston Scientific<\/em>","content":"\u201cLSI offered Nalu Medical a terrific forum in which we: a) increased visibility and understanding the market we were pursuing, b) demonstrated unique attributes of the product technology we developed, c) shared clinical results and, d) outlined our initial commercialization plans and successes.\r\n\r\nLSI also offered an environment where we could speak with relevant lenders, service providers and potential strategics acquirers. Proudly we can point to a successful exit to Boston Scientific.\u201d","logo":"https:\/\/media.lifesciencemarketresearch.com\/70788\/conversions\/nalu-small.png","headset":"https:\/\/media.lifesciencemarketresearch.com\/70789\/conversions\/1771964808344-small.png","name":"Thomas West","job_title":"President, CEO, Director, Nalu Medical","order":5},{"id":7,"type":"text","title":"Completed Series A Extension of $3 Million in Oversubscribed Round","styled_title":"Completed Series A Extension of $3 Million in Oversubscribed Round<\/em>","content":"\"When we started raising in February, I had cold emailed Sean Churchill at cultivate(MD) and told him I'd be at LSI in March. We met for the first time at the event and less than 6 weeks later, he and his team had joined our Series A extension round. That in person meeting at LSI was key to making this happen.\"","logo":"https:\/\/media.lifesciencemarketresearch.com\/41913\/conversions\/USA-'24-Templates-(Base-Templates---Do-not-Edit)-(1)-(1)-small.png","headset":"https:\/\/media.lifesciencemarketresearch.com\/41853\/conversions\/1-(6)-small.png","name":"Joanna Nathan","job_title":"Co-Founder & CEO of Prana Surgical","order":6},{"id":5,"type":"text","title":"Raised \u00a35M in Funding led by Mercia Ventures","styled_title":"Raised \u00a35M in Funding led by Mercia Ventures<\/em>","content":"We attended an LSI event for the first time in 2023, as part of our fund-raising efforts.\u00a0 The meeting provided a great forum and a fantastic blend of early-stage technology companies seeking to grow, strategics looking for deals, and investors with an appetite and dry powder to invest. \u00a0\u00a0We were fortunate to meet with Mercia Ventures at LSI and within six months had closed the round.\u00a0 I would recommend it strongly to anyone looking to cost-effectively grow their network in this space, and maybe even secure a deal.","logo":"https:\/\/media.lifesciencemarketresearch.com\/42250\/conversions\/alesi_surgical-small.png","headset":"https:\/\/media.lifesciencemarketresearch.com\/41847\/conversions\/1-(4)-small.png","name":"Dominic Griffiths","job_title":"CEO of Alesi Surgical","order":9},{"id":30,"type":"text","title":"Closed $4.1 million Oversubscribed Seed Prime II led by cultivate (MD)","styled_title":"Closed $4.1 million Oversubscribed Seed Prime II led by cultivate (MD)<\/em>","content":"\u201cWe found LSI\u2019s Emerging Medtech Summits to be an invaluable platform for connecting with investors, strategic partners, and industry leaders, helping to elevate Nanochon\u2019s visibility and catalyze meaningful funding conversations that contributed to this round.\u201d","logo":"https:\/\/media.lifesciencemarketresearch.com\/70784\/conversions\/Nanochon-Logo_001.1-13-small.png","headset":"https:\/\/media.lifesciencemarketresearch.com\/70785\/conversions\/1651364428377-small.png","name":"Benjamin Holmes","job_title":"CEO, Nanochon","order":10},{"id":2,"type":"text","title":"Raised \u00a33.8M ($4.8M) in a funding round led by Mercia Ventures","styled_title":"Raised \u00a33.8M ($4.8M)<\/em> in a funding round led by Mercia Ventures","content":"\"Our journey with Mercia Ventures exemplifies the value of LSI's network and events. I first connected with Robert Hornby at LSI Europe in September 2023, which led to our initial introduction to Mercia. While the timing wasn\u2019t right then, the LSI connection put Scalpel on Mercia's radar. Six months later, we were reintroduced through Jason Foster, and by then, Mercia was already familiar with our progress and chose to invest. This perfectly illustrates how investors build conviction through multiple touchpoints over time\u2014and LSI played a crucial role in initiating that relationship.\"","logo":"https:\/\/media.lifesciencemarketresearch.com\/41840\/conversions\/1-small.png","headset":"https:\/\/media.lifesciencemarketresearch.com\/41841\/conversions\/1-(1)-small.png","name":"Yeshwanth Pulijala","job_title":"Founder & CEO of Scalpel AI","order":11},{"id":11,"type":"video","thumbnail":"https:\/\/media.lifesciencemarketresearch.com\/41859\/conversions\/01-medium.jpg","youtube_id":"XP5_vklePPE","name":"Robert Krummen","job_title":"Vektor Medical | LSI Testimonial","order":12},{"id":6,"type":"text","title":"Completed \u20ac44M Series B Financing","styled_title":"Completed \u20ac44M Series B Financing<\/em>","content":"\"I personally, and CorFlow, owe a debt of gratitude to LSI on the path to get us to our monumental financing round. I was introduced to our first lead investor at LSI Europe, which was a rare opportunity given he represented a prominent US VC firm \u2013 the concentrated connection environment LSI provided there made it possible. \r\n\r\nAt LSI USA, I met with others who eventually joined our syndicate. I also met fellow CEOs who gave sage advice on stage and over dinners, and are now friends, and can credit a chance encounter in the lobby at the USA event for meeting a lead at the search firm who now helped us make our first US hires, post-close.\r\n\r\nThank you to LSI for the role you play in the ecosystem here with startups, strategics, investors, and service providers \u2013 I will be back, and recommend this to others in my shoes.\u201d","logo":"https:\/\/media.lifesciencemarketresearch.com\/41850\/conversions\/CorFlow-Logo-1-small.png","headset":"https:\/\/media.lifesciencemarketresearch.com\/41851\/conversions\/1-(5)-small.png","name":"Paul Mead","job_title":"CEO of CorFlow","order":13},{"id":25,"type":"video","thumbnail":"https:\/\/media.lifesciencemarketresearch.com\/41873\/conversions\/16-medium.jpg","youtube_id":"dI7WkOqe53s","name":"Murielle Thinard McLane","job_title":"Intuitive Surgical | LSI Testimonial","order":14},{"id":12,"type":"video","thumbnail":"https:\/\/media.lifesciencemarketresearch.com\/41860\/conversions\/05-medium.jpg","youtube_id":"YvoPXOLapUs","name":"Hamed Hanafi","job_title":"Novaresp Technologies | Testimonial, LSI Europe '24","order":15},{"id":9,"type":"text","title":"Co-Led $16M Series A Investment in Vektor Medical","styled_title":"Co-Led $16M Series A Investment in Vektor Medical<\/em>","content":"\"During LSI Europe '23, we had the opportunity to meet with the management team of Vektor Medical. We were impressed by the depth of their knowledge and their dedication to revolutionize arrhythmia care. It was their team's clear vision for their vMap product that motivated us to dive deeper and ultimately invest. Their commitment and drive were the catalyst for our belief in Vektor's groundbreaking product.\"","logo":"https:\/\/media.lifesciencemarketresearch.com\/41856\/conversions\/TVM_LOGO_RGB_NEU-1-small.png","headset":"https:\/\/media.lifesciencemarketresearch.com\/41857\/conversions\/1-(8)-small.png","name":"Dr. Luc Mareng\u00e8re","job_title":"Managing Partner at TVM Capital Life Science","order":16},{"id":21,"type":"video","thumbnail":"https:\/\/media.lifesciencemarketresearch.com\/41869\/conversions\/14-medium.jpg","youtube_id":"3k1qcCBCODo","name":"Luc Marengere","job_title":"TVM Capital | LSI Testimonial","order":17},{"id":4,"type":"text","title":"Co-Led a \u20ac17.9M Series B Investment Round for Lymphatica Medtech","styled_title":"Co-Led a \u20ac17.9M Series B<\/em> Investment Round for Lymphatica Medtech","content":"\"Lymphatica has developed the first clinical solution for a huge unmet need - lymphedema, affecting tens of millions of patients in the US and EU alone. I met Lymphatica at LSI Europe '23 in Barcelona. LSI helped me discover the opportunity and exchange ideas with potential co-investors about the disease and solution.\"","logo":"https:\/\/media.lifesciencemarketresearch.com\/41844\/conversions\/logo-2-1-small.png","headset":"https:\/\/media.lifesciencemarketresearch.com\/41848\/conversions\/1-(3)-small.png","name":"Alessio Beverina","job_title":"Co-Founder & General Partner at Panakes Partners","order":18},{"id":13,"type":"video","thumbnail":"https:\/\/media.lifesciencemarketresearch.com\/41861\/conversions\/02-medium.jpg","youtube_id":"bjoPHxc-VZ0","name":"David Neale","job_title":"Arga Medtech | Testimonial, LSI Europe '24","order":19},{"id":3,"type":"text","title":"Invested in Prana Surgical's Series A Extension of $3M","styled_title":"Invested in Prana Surgical\u2019s Series A Extension of $3M<\/em>","content":"We at cultivate(MD) have been attending and participating at LSI for years. Two weeks before the meeting, I was looking over the LSI app and was identifying portfolio companies and CEOs that we were interested in learning more about. When Joanna Nathan sent me an email, it was so easy to look up Prana Surgical to learn more. I used the LSI app and scheduled a meeting time and location with Joanna Nathan. We were all set 2 weeks before the meeting even started. This connection likely wouldn't have occurred without LSI.","logo":"https:\/\/media.lifesciencemarketresearch.com\/41842\/conversions\/cultivateMD-logo-transparent-1-small.png","headset":"https:\/\/media.lifesciencemarketresearch.com\/41849\/conversions\/1-(2)-small.png","name":"R. Sean Churchill","job_title":"MD, MBA, Managing Director, cultivate(MD)","order":20},{"id":14,"type":"video","thumbnail":"https:\/\/media.lifesciencemarketresearch.com\/41862\/conversions\/04-medium.jpg","youtube_id":"zEN3kej2-Rs","name":"Elizabeth Hoff","job_title":"SOMAVAC | Testimonial, LSI Europe '24","order":21},{"id":10,"type":"video","thumbnail":"https:\/\/media.lifesciencemarketresearch.com\/41858\/conversions\/03-medium.jpg","youtube_id":"fB7yMqHXnVc","name":"Martin Herman","job_title":"Powerful Medical | Testimonial, LSI Europe '24","order":22},{"id":8,"type":"text","title":"Raised a $22M Funding Round","styled_title":"Raised a $22M Funding Round<\/em>","content":"\"Closing this $22 million oversubscribed funding round is a testament to the dedication and excellence of our team, as well as the support from our early investors.\u201d On LSI\u2019s role, Toon shares: \u201cSince our initial participation at LSI Europe '23, we have continually engaged with top investors and strategic partners. We are grateful to LSI for the numerous contacts and networking opportunities that have supported this deal.\"","logo":"https:\/\/media.lifesciencemarketresearch.com\/41854\/conversions\/Vitestro-logo-RGB-1-small.png","headset":"https:\/\/media.lifesciencemarketresearch.com\/41855\/conversions\/1-(7)-small.png","name":"Toon Overbeeke","job_title":"CEO & Co-Founder of Vitestro","order":23}],"links":{"first":"https:\/\/www.lifesciencemarketresearch.com\/testimonials\/data?page=1","last":"https:\/\/www.lifesciencemarketresearch.com\/testimonials\/data?page=2","prev":null,"next":"https:\/\/www.lifesciencemarketresearch.com\/testimonials\/data?page=2"},"meta":{"current_page":1,"from":1,"last_page":2,"links":[{"url":null,"label":"« Previous","active":false},{"url":"https:\/\/www.lifesciencemarketresearch.com\/testimonials\/data?page=1","label":"1","active":true},{"url":"https:\/\/www.lifesciencemarketresearch.com\/testimonials\/data?page=2","label":"2","active":false},{"url":"https:\/\/www.lifesciencemarketresearch.com\/testimonials\/data?page=2","label":"Next »","active":false}],"path":"https:\/\/www.lifesciencemarketresearch.com\/testimonials\/data","per_page":21,"to":21,"total":32}}